— Know what they know.
Not Investment Advice
Also trades as: BETR.CN (CNQ) · $vol 0M

BETRF OTC

BetterLife Pharma Inc.
1W: -20.5% 1M: -7.2% 3M: +47.3% YTD: +569.2% 1Y: +252.4% 3Y: +212.7% 5Y: -17.7%
$0.19
-0.01 (-5.02%)
 
Weekly Expected Move ±19.6%
$0 $0 $0 $0 $0
OTC · Healthcare · Biotechnology · Tech Score Sell · Power 38 · $30.9M mcap · 106M float · 0.127% daily turnover · Short 72% of daily vol

Balance Sheet Trends

Total Assets
$220K -2.1% ▼
5Y CAGR: -30.3%
Total Liabilities
$7M -11.5% ▼
5Y CAGR: +2.5%
Shareholders Equity
-$10M +8.2% ▲
Cash & Investments
$13K +53.9% ▲
5Y CAGR: -39.5%
Total Debt
$906K -30.4% ▼
5Y CAGR: +12.6%
Net Debt
$894K -30.9% ▼

Assets vs Liabilities & Equity

Year-over-Year Growth

View Full Balance Sheet
Line ItemFY2022FY2023FY2024FY2025FY2026
— Assets —
Cash$174K$8K$37K$8K$13K
Short-Term Investments$0$0$0$0$0
Cash & ST Investments$174K$8K$37K$8K$13K
Net Receivables$325K$17K$40K$12K$3K
Inventory$0$0$0$0$0
Other Current Assets$0$0$0$205K$205K
Total Current Assets$1M$75K$325K$225K$220K
Property, Plant & Equip.$18K$0$0$0$0
Goodwill & Intangibles$0$0$0$0$0
Long-Term Investments$0$0$0$0$0
Other Non-Current Assets-$0$0$0$0$0
Total Non-Current Assets$18K$0$0$0$0
Total Assets$1M$75K$325K$225K$220K
— Liabilities —
Accounts Payable$3M$4M$3M$4M$4M
Short-Term Debt$238K$747K$0$871K$878K
Deferred Revenue$305K$963K$0$0$0
Other Current Liabilities$4M-$3M$2M$313K$446K
Total Current Liabilities$4M$7M$7M$8M$7M
Long-Term Debt$899K$440K$328K$49K$27K
Other Non-Current Liab.-$865K$21K$275K$0$0
Total Non-Current Liabilities$899K$461K$1M$49K$27K
Total Liabilities$5M$8M$8M$8M$7M
— Equity —
Common Stock$75M$77M$78M$80M$82M
Retained Earnings-$103M-$112M-$115M-$119M-$120M
Accumulated OCI$24M$25M$26M$28M$28M
Total Stockholders Equity-$4M-$11M-$11M-$11M-$10M
Total Liabilities & Equity$1M$75K$325K$225K$220K
— Key Metrics —
Total Debt$1M$1M$1M$1M$906K
Net Debt$1M$1M$1M$1M$894K
Total Investments$0$0$0$0$0

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms